Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response to PTSC Request for Exclusion of Stockholder Proposal

When the new rules are released on or about Aug,25, 2010 we will know if they can be applied based on the last annual meeting date

I humbly suggest that the effective date will be linked to a Company's 2011 financial year-end date but not before April 1, 2011, and more likely July 1 2011.

.

.

.

Be well

Share
New Message
Please login to post a reply